Cargando…
Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
BACKGROUND: Levosimendan has pharmacologic and hemodynamic advantages over conventional intravenous inotropic agents. It has been used mainly as a rescue drug in the pediatric intensive care unit or in the operating room. We present the largest single-center experience of levosimendan in children. M...
Autor principal: | Suominen, Pertti K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199236/ https://www.ncbi.nlm.nih.gov/pubmed/21974814 http://dx.doi.org/10.1186/1471-2253-11-18 |
Ejemplares similares
-
Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009) -
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020) -
Preoperative optimization with levosimendan in heart failure patient undergoing thoracic surgery
por: Nespoli, Moana Rossella, et al.
Publicado: (2016) -
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010) -
Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)